"Het Erasmus MC Sophia Kinderziekenhuis heeft alles in huis om uw kind de beste zorg te bieden. Het is een innovatief kinderziekenhuis, dat al meer dan 150 jaar bestaat. Alle specialismen op het gebied van kindergeneeskunde, chirurgie en kinderpsychiatrie zijn aanwezig. Ook zijn de afdelingen Verloskunde en Gynaecologie, Klinische Genetica en Urologie aanwezig in en onderdeel van het Erasmus MC-Sophia. De kennis van alle vakgebieden in het kinderziekenhuis komt samen in vier speerpunten: het Kinderthoraxcentrum, het Kinderhersencentrum, het Centrum voor Zeldzame ziekten en het Centrum voor reproductieve, foetale en neonatale geneeskunde."

During the past decade, Erasmus MC / location Sophia Kinderziekenhuis conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Erasmus MC / location Sophia Kinderziekenhuis" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "KU Leuven" with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Mallinckrodt" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erasmus MC / location Sophia Kinderziekenhuis" #1 collaborator was "Sophia Kindergeneeskunde" with 1 trials as a collaborator and "Stollery Children's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Erasmus MC / location Sophia Kinderziekenhuis" are "Angelman Syndrome" (1 trials), "Children" (1 trials), "Critical Illness" (1 trials), "Drug Resistant Epilepsy" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Erasmus MC / location Sophia Kinderziekenhuis" in a lesser frequency.

Most popular intervention types in "Erasmus MC / location Sophia Kinderziekenhuis" are "Drug" (5 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Emicizumab" (1 trials), "Genotropin Pen" (1 trials), "Late parenteral nutrition" (1 trials) and "MARK VII pen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erasmus MC / location Sophia Kinderziekenhuis" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Erasmus MC / location Sophia Kinderziekenhuis". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Erasmus MC / location Sophia Kinderziekenhuis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Erasmus MC / location Sophia Kinderziekenhuis, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".